P134 Radiographic progression of structural joint damage over 5 years of baricitinib treatment in patients with RA: results from RA-BEYOND

被引：0
|
作者：
van der Heijde, Desiree M. F. M. [1 ]
Kartman, Cynthia E. [2 ]
Xie, Li [2 ]
Beattie, Scott [3 ]
Schlichting, Douglas E. [2 ]
Durez, Patrick [4 ]
Tanaka, Yoshiya [5 ]
Fleischmann, Roy [6 ]
机构：
[1] Leiden Univ Med Ctr, Imaging Rheumatol, Leiden, Netherlands
[2] Eli Lilly & Co, Rheumatol, Indianapolis, IN 46285 USA
[3] Eli Lilly & Co, Data & Analyt, Indianapolis, IN 46285 USA
[4] Univ Catholique Louvain St Luc, Rheumatol, Brussels, Belgium
[5] Univ Occupat & Environm Hlth, Rheumatol, Kitakyushu, Fukuoka, Japan
[6] Univ Texas Southwestern Med Ctr Dallas, Rheumatol, Dallas, TX 75390 USA
来源：
RHEUMATOLOGY | 2021年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 31 条
  • [21] Abatacept sustains inhibition of radiographic progression over 2 years in rheumatoid arthritis (RA) patients with an inadequate response to methotrexate (MTX): Results from the long-term extension (LTE) of the AIM trial
    Genant, H. K.
    Peterfy, C.
    Westhovens, R.
    Becker, J. P.
    Aranda, R.
    Teng, J.
    Kremer, J. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 57 - 58
  • [22] U-Act-Early Trial 3 Years Follow-up: Radiographic Joint Damage and Use of Bdmards over 5 Years in Early RA Patients Treated-to-Target with Strategies Initiating Tocilizumab, Methotrexate or Their Combination
    Verhoeven, Maxime M. A.
    de Hair, Maria J. H.
    Welsing, Paco M. J.
    Petho-Schramm, Attila
    Borm, Michelle E. A.
    Teitsma, Xavier M.
    van Laar, Jacob
    Lafeber, Floris P. J. G.
    Bijlsma, Johannes W. J.
    Jacobs, Johannes W. G.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [23] Radiographic Progression and Changes in Inflammation and Structural Damage on Serial MRI Examinations over 5 Years in Patients with Ankylosing Spondylitis Treated with TNF-Alpha Inhibitors
    Pedersen, Susanne Juhl
    Weber, Ulrich
    Nahal, Roula Said
    Sorensen, Inge Juul
    Loft, Anne Gitte
    Tvede, Niels
    Kollerup, Gina
    Juul, Lars
    Thamsborg, Gorm
    Madsen, Ole Rintek
    Moller, Jakob M.
    Balding, Lone
    Jurik, Anne Grethe
    Ostergaard, Mikkel
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [24] Minimal Spinal Radiographic Progression in Patients with Radiographic Axial Spondyloarthritis over 2 Years of Bimekizumab Treatment: Results from a Phase 3 Open-Label Extension Study
    Baraliakos, Xenofon
    Ramiro, Sofia
    Maksymowych, Walter
    Ostergaard, Mikkel
    Massow, Ute
    Vaux, Thomas
    Prajapati, Chetan
    Marten, Alexander
    de Peyrecave, Natasha
    Poddubnyy, Denis
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 3591 - 3593
  • [25] Reduction in Structural Damage Progression and Improvement in Clinical Response with Abatacept Treatment in Patients with ACPA plus , Early RA: Results from a Post Hoc Analysis of the AVERT-2 Study by Baseline Erosion Scores
    Pachai, Chahin
    Connolly, Sean E.
    Tanaka, Yoshiya
    Bykerk, Vivian
    Huizinga, Tom
    Citera, Gustavo
    Bingham, Clifton O., III
    Du, Shuyan
    Hoexter, Godehard
    Fleischmann, Roy
    Banerjee, Subhashis
    Emery, Paul
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 599 - 602
  • [26] MINIMAL SPINAL RADIOGRAPHIC PROGRESSION IN PATIENTS WITH RADIOGRAPHIC AXIAL SPONDYLO ARTHRITIS OVER 2 YEARS OF BIMEKIZUMAB TREATMENT: RESULTS FROM A PHASE 3 OPEN-LABEL EXTENSION STUDY
    Baraliakos, X.
    Ramiro, S.
    Maksymowych, W. P.
    Ostergaard, M.
    Massow, U.
    Fleurinck, C.
    Vaux, T.
    Prajapati, C.
    Marten, A.
    de Peyrecave, N.
    Poddubnyy, D.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2024, 42 (09) : 69 - 70
  • [27] Longterm Safety, Efficacy, and Inhibition of Structural Damage Progression Over 5 Years of Treatment with Abatacept in Patients with Rheumatoid Arthritis in the Abatacept in Inadequate Responders to Methotrexate Trial
    Kremer, Joel M.
    Peterfy, Charles
    Russell, Anthony S.
    Emery, Paul
    Abud-Mendoza, Carlos
    Sibilia, Jean
    Becker, Jean-Claude
    Westhovens, Rene
    Genant, Harry K.
    JOURNAL OF RHEUMATOLOGY, 2014, 41 (06) : 1077 - 1087
  • [28] Abatacept (ABA) slows radiographic progression over 2 yrs in rheumatoid arthritis (RA) patients (Pts) with an inadequate response to methotrexate (MTX): Results from the long-term extension (LTE) of the AIM trial
    Westhovens, R.
    Peterfy, C.
    Vratsanos, G.
    Becker, J. C.
    Aranda, R.
    Teng, J.
    Kremer, J.
    Genant, H. K.
    RHEUMATOLOGY, 2007, 46 : I15 - I16
  • [29] The impact of initial aggressive drug treatment with DMARDs on the development of joint damage in the long term in patients with rheumatoid arthritis (RA). The 5-year experience from the FIN-RACo study.
    Korpela, M
    Mottonen, T
    Laasonen, L
    Kautiainen, H
    Hannonen, P
    Lerisalo-Repo, M
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S153 - S153
  • [30] Clinical Responses and Patient Flow over 2 Years of Treatment with Abatacept, Including Dose De-Escalation, in Patients with Early, MTX-Naive, ACPA plus RA: Results from a Phase IIIb Study
    Emery, Paul
    Tanaka, Yoshiya
    Bykerk, Vivian
    Bingham, Clifton, III
    Huizinga, Thomas
    Citera, Gustavo
    Huang, Kuan-Hsiang Gary
    Connolly, Sean
    Elbez, Yedid
    Wong, Robert
    Lozenski, Karissa
    Fleischmann, Roy
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
1234